Medicare Enrolled
Dr. Anup Lal, MD
Hematology & Oncology · Port Huron, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lal
Dr. Anup Lal is a hematology & oncology specialist in Port Huron, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lal performed 3,452 Medicare services across 1,630 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lal received a total of $7,240 from 55 pharmaceutical and/or device companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 23% volume in MI
$7,240 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,452
Medicare services
Top 23% in MI for hematology & oncology
1,630
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~182 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,023 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
496 | $95 | $150 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
385 | $8 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
290 | $0 | $0 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
280 | $38 | $108 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $62 | $159 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
99 | $137 | $352 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
88 | $20 | $80 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
84 | $96 | $306 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $120 | $351 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
55 | $134 | $400 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
51 | $11 | $66 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $10 | $52 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
39 | $1 | $5 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $103 | $300 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
31 | $25 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
30 | $94 | $214 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
29 | $61 | $140 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
28 | $1 | $5 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
25 | $46 | $200 |
| New patient office visit, complex (60-74 min) | 25 | $167 | $442 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
17 | $39 | $85 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $81 | $230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.7% high complexity
12.1% medium
82.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,240
Total received (2018-2024)
Avg $1,034/year across 7 years
Top 25% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
385
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,792 (93.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$448 (6.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,953
2023
$688
2022
$308
2021
$575
2020
$689
2019
$1,431
2018
$1,596
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$422
Novartis Pharmaceuticals Corporation
$155
Genentech USA, Inc.
$147
Astellas Pharma US Inc
$136
PFIZER INC.
$101
Merck Sharp & Dohme LLC
$96
Daiichi Sankyo Inc.
$84
SOBI, INC
$84
Janssen Biotech, Inc.
$84
ABBVIE INC.
$80
GENZYME CORPORATION
$62
Takeda Pharmaceuticals U.S.A., Inc.
$52
GlaxoSmithKline, LLC.
$50
Eisai Inc.
$49
Karyopharm Therapeutics Inc.
$47
BeiGene USA, Inc.
$46
Ipsen Biopharmaceuticals, Inc
$38
Incyte Corporation
$27
Acrotech Biopharma Inc.
$24
EMD Serono, Inc.
$23
Lilly USA, LLC
$23
ImmunoGen, Inc.
$21
Gilead Sciences, Inc.
$20
Kite Pharma, Inc.
$19
ARRAY BIOPHARMA INC
$19
Mirati Therapeutics, Inc.
$16
Inari Medical, Inc.
$16
Celgene Corporation
$13
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,094
AstraZeneca Pharmaceuticals LP
$658
Janssen Biotech, Inc.
$589
Amgen Inc.
$477
PFIZER INC.
$468
Merck Sharp & Dohme Corporation
$351
Genentech USA, Inc.
$315
Celgene Corporation
$278
Astellas Pharma US Inc
$236
GENZYME CORPORATION
$202
E.R. Squibb & Sons, L.L.C.
$168
Daiichi Sankyo Inc.
$153
Lilly USA, LLC
$135
Rigel Pharmaceuticals, Inc.
$127
Merck Sharp & Dohme LLC
$125
GlaxoSmithKline, LLC.
$103
Seagen Inc.
$98
BeiGene USA, Inc.
$98
TESARO, Inc.
$95
SOBI, INC
$84
AMAG Pharmaceuticals, Inc.
$83
ABBVIE INC.
$80
Incyte Corporation
$79
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Ipsen Biopharmaceuticals, Inc
$75
Puma Biotechnology, Inc.
$74
Pharmacyclics LLC, An AbbVie Company
$71
Gilead Sciences, Inc.
$68
Eisai Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$64
Karyopharm Therapeutics Inc.
$47
Janssen Pharmaceuticals, Inc
$44
Novo Nordisk Inc
$42
Regeneron Healthcare Solutions, Inc.
$40
ARRAY BIOPHARMA INC
$37
EMD Serono, Inc.
$34
Kite Pharma, Inc.
$33
AbbVie, Inc.
$32
AbbVie Inc.
$32
TerSera Therapeutics LLC
$30
Exelixis Inc.
$27
Alexion Pharmaceuticals, Inc.
$25
Acrotech Biopharma Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$23
EISAI INC.
$21
ImmunoGen, Inc.
$21
Taiho Oncology, Inc.
$20
Agios Pharmaceuticals, Inc.
$16
Mirati Therapeutics, Inc.
$16
Inari Medical, Inc.
$16
Deciphera Pharmaceuticals Inc.
$15
AVEO Pharmaceuticals, Inc.
$15
Fortovia Therapeutics, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 32.3% of all-time payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · Abraxane · Alecensa · Aranesp · Avastin · BELEODAQ · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ENHERTU · ERBITUX · ERLEADA · Enhertu · Erleada · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MVASI · MYLOTARG · NERLYNX · Nerlynx · Neulasta · NovoSeven RT · Nplate · OJJAARA · OPDIVO · Onivyde · PADCEV · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · S · SANDOSTATIN · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SUTENT · Soltamox · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · VENCLEXTA · VERZENIO · Vanflyta · Vectibix · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZOLADEX · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
3
Per 100K population
1.9
County median income
$69,349
Nearest hospital
LAKE HURON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lal is a clinical cardiology specialist, with above-average Medicare volume (top 23% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lal experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Lal performed 1,023 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lal receive payments from pharmaceutical companies?
Yes. Dr. Lal received a total of $7,240 from 55 companies across 385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lal's costs compare to other hematology & oncology specialists in Port Huron?
Dr. Lal's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Port Huron
Browse hematology & oncology specialists in Port Huron ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology